Around $10bn is being spent on finding a vaccine for coronavirus—it’s not nearly enough. And even when a covid-19 vaccine is found how should it be distributed fairly? Our experts answer your questions.
00:00 Covid-19: When will a vaccine be ready?
00:50 Will there ever be a “silver-bullet” vaccine?
01:41 How long would it take for the whole world to be vaccinated?
02:25 Who benefits financially from the vaccine?
03:54 How much will each vaccine cost?
05:10 What percentage of Americans do you estimate will choose not to get vaccinated, and how much of an issue will this be?
06:44 In an ideal world, how should a vaccine be optimally distributed?
07:21 Will new versions of the vaccine be required periodically?
07:54 Will developing countries receive equal access to the vaccine, or will they be left behind?
08:50 Should richer countries pay for vaccines in the developing world?
10:01 How should we respond to crises like this one in the future?
Further reading:
Find The Economist’s most recent coverage of covid-19 here: [ Ссылка ]
Sign up to The Economist’s daily newsletter to keep up to date with our latest covid-19 coverage: [ Ссылка ]
Listen to “The Intelligence” podcast about the vaccine candidates and equitable distribution: [ Ссылка ]
How the world can think better about catastrophic and existential risks: [ Ссылка ]
Read our leader on how people must adapt to living in the covid-19 pandemic era: [ Ссылка ]
How SARS-CoV-2 causes disease and death in covid-19: [ Ссылка ]
Covid-19 testing labs are being overwhelmed: [ Ссылка ]
How the pandemic has shown the urgency of reforming care for the elderly: [ Ссылка ]
Read about the hunt for the origins of covid-19: [ Ссылка ]
